Xaga Surgical Secures 700 k to Revolutionize Medical Needles and Expand to the U.S.
Briefly

Xaga Surgical, a HealthTech startup from Helsingborg, has secured €700,000 to enhance its innovative medical needles, minimizing infection risks and improving cancer diagnostics. Founded by urologist Dr. Andreas Forsvall, the startup aims to revolutionize needle design following alarming instances of sepsis in patients post-prostate biopsies. With this funding, Xaga plans to commercialize its patented technology, achieving FDA approval, and expanding into the U.S. market, ultimately addressing the health issues related to needle infections that affect over 50 million individuals annually.
The global market for medical needles faces significant challenges. Over 50 million people annually risk health problems linked to needle infections, with estimated costs of $80 billion USD.
Our investment in Xaga Surgical is an example of how we support innovations that make a real difference. Through their groundbreaking technology, we contribute to safer healthcare overall.
Read at resund Startups
[
|
]